Monte Rosa Therapeutics, Inc. (GLUE) dividend history
GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3039% above fair value
$9.07−0.09 (-0.98%)
Close on Nov 17, 2026Market cap $773.79MP/E –Yield –
Dividends
Monte Rosa Therapeutics has not reported a dividend
No dividend per share appears in Monte Rosa Therapeutics's annual filings since fiscal 2019.
See a number that looks wrong?